Category : Search result: hedge fund profits


X UK Profits Slump 65% as Advertisers Flee

Turnover at Elon Musk's X in the UK collapsed from £69.1m to £28.8m in 2024. The platform faces a brand safety crisis and political pressure. Read the full financial breakdown.

US Suspends Funds for Needy Families in Five States

The Trump administration suspends grants for child care and family assistance in California, Colorado, Illinois, Minnesota, and New York, citing fraud allegations. Governors vow legal action.

Yves Masselin leaves Eisler Capital for Verition

Senior money manager Yves Masselin departs Eisler Capital to join rival hedge fund Verition in London, marking a significant hire for the multi-strategy firm. Read the full story.

Next's bumper Christmas but warns of tough 2026

Retail giant Next reports a 10.6% sales surge over Christmas, raising its profit forecast to £1.15bn. However, it cautions of a tough year ahead amid a worsening UK jobs market. Read the full analysis.

Capula Investment Management fees drop 48%

London hedge fund Capula Investment Management saw its performance fees crash by 48% last year. Discover the figures and strategic shifts behind this significant decline.

Jain Global Hires Senior JPMorgan Bond Trader

Bobby Jain's hedge fund startup, Jain Global, has secured a senior bond trader from JPMorgan. Discover the strategic hires shaping this major new player in London's finance scene.

One Four Nine Fund cuts losses amid sale talks

Copper Street Capital's One Four Nine fund reduced its annual loss to £1.4m as parent company enters exclusive sale negotiations. Discover the latest on this London investment story.

Ilex Capital hedge fund pays top earner £78m

Former Citadel traders' London hedge fund, Ilex Capital, paid its highest-earning partner £78m last year as assets surged. Discover the fund's remarkable performance and key figures.

Pension Funds Eye £4.5bn Center Parcs Stake

Major UK public sector pension schemes are negotiating to acquire a significant stake in holiday giant Center Parcs, valued at £4.5bn. Read the full story on the landmark investment.

Pfizer spent 18% on R&D, 27% to shareholders in 2024

Analysis reveals US pharma giant Pfizer allocated more revenue to shareholders than R&D in 2024, as Trump's drug price rhetoric targets allies over corporate profits. Explore the real drivers of high US medicine costs.

Page 1 of 4